J. Chang

发表

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer.

T. Powles, Jenny C. Chang, T. Hickish, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic relavance of cerbB2 expression following neoadjuvant chemotherapy in patients in a randomised trial of neoadjuvant versus adjuvant chemoendocrine therapy

T. Powles, M. Dowsett, Jenny C. Chang, 2004, Breast Cancer Research and Treatment.

TBCRC 006: A multicenter phase II study of neoadjuvant lapatinib and trastuzumab in patients with HER2-overexpressing breast cancer.

R. Schiff, M. Goetz, C. Osborne, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients.

T. Powles, M. Dowsett, Jenny C. Chang, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Short Communication Phase II Trial of rhIL-6 (Interleukin-6) Prior to and Concurrently with VAD (Vincristine, Doxorubicin and Dexamethasone) Chemotherapy for Patients with Multiple Myeloma

M. Ranson, B. Lord, J. Chang, 1997 .

Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma.

M. Ranson, B. Lord, J. Chang, 1997, European journal of cancer.

Variation in endometrial thickening in women with amenorrhea on tamoxifen

T. Powles, M. Dowsett, S. Ashley, 1998, Breast Cancer Research and Treatment.

Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study.

J. Albanell, M. Campone, P. Fumoleau, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer

S. Hilsenbeck, R. Elledge, J. Chang, 2009, Breast Cancer Research and Treatment.

Sacituzumab Govitecan, a Trop-2-Directed Antibody-Drug Conjugate, for Patients with Epithelial Cancer: Final Safety and Efficacy Results from the Phase 1/2 IMMU-132-01 Basket Trial.

J. Berlin, A. Bardia, J. Lang, 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

Platinum-Taxol non-cross resistance in epithelial ovarian cancer.

M. Gore, M. Nicolson, R. A’Hern, 1995, British Journal of Cancer.

Gene Expression Profiles Differentiating Between Breast Cancers Clinically Responsive or Resistant to Letrozole

J. Chang, B. Dave, J. Chang, 2010 .

Prediction of Docetaxel Response in Human Breast Cancer by Gene Expression Profiling

J. Chang, J. Chang, 2005 .

Lung cancer in nonsmoking women. Histology and survival patterns

R C Brownson, R. Brownson, J. Myers, 1995, Cancer.

Intensive combination chemotherapy with vincristine, adriamycin and prednisolone (VAP) in the treatment of diffuse histology non-Hodgkin's lymphoma. (A report of 89 cases with extensive disease from the Manchester Lymphoma Group).

D. Deakin, P. Wilkinson, D. Crowther, 1980, European journal of cancer.

High dose combination chemotherapy with ifosfamide, cyclophosphamide or cisplatin, mitomycin C and mustine with autologous bone marrow support in advanced non-small cell lung cancer. A phase I/II study.

N. Thatcher, J. Chang, S. Gomm, 1991, British Journal of Cancer.

A combinatorial biomarker predicts pathologic complete response to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2+ breast cancer.

S. Hilsenbeck, R. Schiff, J. Reis-Filho, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study.

T. Powles, S. Ashley, J. Chang, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS).

E. Warner, J. Dancey, E. Franssen, 1998, British Journal of Cancer.

Muscular pseudotumor of the breast following doxorubicin and radiation therapy for oat cell carcinoma of the lung

J. Chang, G. Wergowske, D. Marger, 1982, Cancer.

Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

H. Kohrt, J. Berek, A. Secord, 2016, Journal of Immunotherapy for Cancer.

Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study

Hung-Ming Wang, P. Lou, M. Tsai, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase II study of the sequential administration of dacarbazine and fotemustine in the treatment of cerebral metastases from malignant melanoma.

M. Gore, Jenny C. Chang, R. A’Hern, 1994, European journal of cancer.

Carcinosarcoma of the ovary: incidence, prognosis, treatment and survival of patients.

M. Gore, C. Fisher, R. A’Hern, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

A phase I trial of bryostatin 1 in patients with advanced malignancy using a 24 hour intravenous infusion.

G. Jayson, P. Stern, D. Crowther, 1995, British Journal of Cancer.

DNA repair signature is associated with anthracycline response in triple negative breast cancer patients

A. Makris, G. Chamness, C. Osborne, 2010, Breast Cancer Research and Treatment.

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer.

C. Osborne, T. Powles, M. Dowsett, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathological features and BRCA1 mutation screening in premenopausal breast cancer patients.

J. Sng, S. Hilsenbeck, J. Chang, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

A review of breast cancer chemoprevention.

J. Chang, J. Chang, 1998, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

The effects of norethisterone on endometrial abnormalities identified by transvaginal ultrasound screening of healthy post-menopausal women on tamoxifen or placebo.

T. Bourne, W. Collins, J. Davey, 1998, British Journal of Cancer.

Predicting clinical endocrine response in advanced breast cancers using a reproducible low-dimensional biomarker

A. Bild, A. Cohen, A. Nath, 2021, medRxiv.

Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast

Jenny C. Chang, B. Teh, M. Schwartz, 2014, British Journal of Cancer.

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma

T. Powles, M. Dowsett, S. Ashley, 2000, Cancer.

Studies of the Potential Utility of Ki67 as a Predictive Molecular Marker of Clinical Response in Primary Breast Cancer

T. Powles, M. Dowsett, L. Assersohn, 2003, Breast Cancer Research and Treatment.

Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype

J. Chang, J. Chang, 2007 .

Trastuzumab retreatment after relapse on adjuvant trastuzumab therapy for human epidermal growth factor receptor 2-positive breast cancer: final results of the Retreatment after HErceptin Adjuvant trial.

J. Jassem, V. Semiglazov, R. Bell, 2014, Clinical oncology (Royal College of Radiologists (Great Britain)).

Differential responses to chemoimmunotherapy in patients with metastatic malignant melanoma.

M. Gore, P. Mainwaring, P. Guillou, 1997, European journal of cancer.

Clubbing, arthralgia and haemoptysis in a patient with metastatic carcinoma of the breast.

T. Powles, J. Chang, R. Gregory, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.

Nausea and vomiting in cancer patients: an expression of psychological mechanisms?

J. Chang, J. C. Chang, 1981, Psychosomatics.

Genomic approaches in the management and treatment of breast cancer

S. Hilsenbeck, S. Fuqua, J. Chang, 2005, British Journal of Cancer.

A randomised trial of six versus twelve courses of chemotherapy in metastatic carcinoma of the breast.

T. Powles, J. Chang, R. Gregory, 1997, European journal of cancer.

A phase I study of dasatinib and weekly paclitaxel for metastatic breast cancer.

C. Hudis, L. Norton, P. Morris, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.